NEW YORK (GenomeWeb News) - Bruker BioSciences’ shares bolted up 19.5 percent today following this morning’s announcement that it is buying its affiliate Bruker BioSpin for $914 million in cash and stock.
 
In afternoon trading, Bruker’s shares had risen $1.87 to $11.16.
 
Bruker BioSpin makes magnetic resonance core technology. It posted $447 million in revenue and $56.6 million in net income in 2006.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.